Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Apr;11(4):573-85.
doi: 10.2217/pgs.10.37.

Use of transcriptomics in understanding mechanisms of drug-induced toxicity

Yuxia Cui  1 , Richard S Paules
Affiliations
Review

Use of transcriptomics in understanding mechanisms of drug-induced toxicity

Yuxia Cui et al. Pharmacogenomics. 2010 Apr.

Abstract

Adverse drug reactions (ADRs) are an important clinical issue and a serious public health risk. Understanding the underlying mechanisms is critical for clinical diagnosis and management of different ADRs. Toxicogenomics can reveal impacts on biological pathways and processes that had not previously been considered to be involved in a drug response. Mechanistic hypotheses can be generated that can then be experimentally tested using the full arsenal of pharmacology, toxicology, molecular biology and genetics. Recent transcriptomic studies on drug-induced toxicity, which have provided valuable mechanistic insights into various ADRs, have been reviewed with a focus on nephrotoxicity and hepatotoxicity. Related issues have been discussed, including extrapolation of mechanistic findings from experimental model systems to humans using blood as a surrogate tissue for organ damage and comparative systems biology approaches.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Complete toxicogenomic study
Factors that need to be considered in each stage of the study are listed in the right column.
See this image and copyright information in PMC

References

    1. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356(9237):1255–1259. - PubMed
    1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients – a meta-analysis of prospective studies. JAMA. 1998;279(15):1200–1205. - PubMed
    1. Moore TJ, Cohen MR, Furberg CD. Serious adverse drug events reported to the Food and Drug Administration, 1998–2005. Arch. Intern. Med. 2007;167(16):1752–1759. - PubMed
    1. Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N. Engl. J. Med. 2003;348(16):1556–1564. - PubMed
    1. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. Br. Med. J. 2004;329(7456):15–19. - PMC - PubMed

Publication types

MeSH terms